| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1565 | Crebbp-in-9 | Novel CREBBP Bromodomain Inhibitor |
|
| DCC1566 | Cremastranone | Natural antiangiogenic homoisoflavanone, inhibiting the proliferation, migration and tube formation ability of human retinal microvascular endothelial cells |
|
| DCC1567 | Cribrostatin 6 | Antineoplastic and Antibacterial; Inducer of death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism; Dark blue cancer cell growth inhibitor |
|
| DCC1568 | Crl-40940 | Selective dopaminergic reuptake inhibitor |
|
| DCC1569 | Crom-1 | Novel potent, selective, and reversible inhibitor of human monoamine oxidase B (hMAO-B) |
|
| DCC1570 | Crom-2 | Novel potent, selective, and reversible inhibitor of human monoamine oxidase B (hMAO-B) |
|
| DCC1571 | Crs400359 | Novel potent and mycobacteria-specific antimycobacterial agent, targeting MmpL3, improving the antimycobacterial activity and being also potent against Mtb |
|
| DCC1572 | Crs400393 | Novel potent and mycobacteria-specific antimycobacterial agent, targeting MmpL3, a mycobacterial mycolic acid transporterr, demonstrating MIC = 0.03, 2, and ≤ 0.12 μg/mL against Mabs, Mycobacterium avium complex (MAC), and Mtb respectively |
|
| DCC1573 | Crt0083914 | Potent and selective inhibitor of AKR1C3 |
|
| DCC1574 | Crt0093964 | Potent and selective inhibitor of AKR1C3 |
|
| DCC1575 | Crth2 Antagonist K117 | Potent and selective CRTH2 antagonist |
|
| DCC1576 | Crx-526 | TLR4 antagonist, protecting against advanced diabetic nephropathy |
|
| DCC1577 | Crx-527 | Novel potent powerful lipid A analogue as a conjugation-ready TLR4 ligand |
|
| DCC1578 | Cryosim-1 | Novel TRPM8 agonist |
|
| DCC1579 | Cryosim-3 | Novel water-soluble, potent, and selective TRPM8 receptor agonist |
|
| DCC1580 | Cryptopleurine | Inhibitor of gene products associated with cell survival, proliferation, invasion, and angiogenesis, targeting NF-κB pathway, showing antiproliferative activity and unique mode of action |
|
| DCC1581 | Cryptozepine-2 | Novel photoisomerizable potent and selective M1 ligand, mimicing the tricyclic chemical structure and display reversibly controlled activity, showing stronger inhibition upon illumination both in vitro and in cardiac atria ex vivo |
|
| DCC1582 | Csl-32 | Novel modulator of PI3K and NF-κB activities, blocking migration and production of inflammatory mediators |
|
| DCC1583 | C-src-in-12 | Novel substrate-competive c-Src inhibitor |
|
| DCC1584 | Csv0c018875 Hydrochloride | Novel G9a (EHMT2) inhibitor, binding tightly inside the active site cavity of G9a, inhibiting the activity of G9a in both enzyme and cell based assays with much lesser toxicity than BIX-0129 |
|
| DCC1585 | Ct-2584 | Dual inhibitor of angiogenesis and lysophosphatidic acid acyltransferase |
|
| DCC1586 | Ct-711 | Novel potent dual inhibitor of ALK and c-Met |
|
| DCC1587 | Ct-mz1 | Novel cell permeable degrader of BRD4 |
|
| DCC1588 | Ctr-21 | Novel anticancer agent, effectively killing multi-drug resistant cancer cells and a panel of different cancer cells originated from a variety of different tissues including breast and skin, preventing tubulin polymerization, leading to the cell cycle arre |
|
| DCC1589 | Ctr-32 | Novel anticancer agent, effectively killing multi-drug resistant cancer cells and a panel of different cancer cells originated from a variety of different tissues including breast and skin, preventing tubulin polymerization, leading to the cell cycle arre |
|
| DCC1590 | Ctt-54.2 Potassium | Inhibitor of prostate-specific membrane antigen (PSMA) |
|
| DCC1591 | Ctw0415 | Novel Serotonin 5-HT 2C Receptor Positive Allosteric Modulator (PAM) with Enhanced Drug-like Properties |
|
| DCC1592 | Cu-6pmn | Novel fluorescent RXR agonist |
|
| DCC1593 | Cugamycin | Novel r(CUG) repeat expansion cleaver, specifically recognizing the 3-dimensional structure of r(CUG)exp, cleaving it more selectively among transcripts containing short, nonpathogenic r(CUG) repeats than an oligonucleotide that recognizes RNA sequence vi |
|
| DCC1594 | Cumi-101 | 5-HT1A receptor agonist |
|
